Meprina-β în lichidul cefalorahidian, nou biomarker în boala Alzheimer

A recent study found elevated levels of the protein meprin-β in the brains and cerebrospinal fluid of Alzheimer's patients, suggesting a link to disease progression. The research indicates that active meprin-β levels increase as Alzheimer's advances, potentially correlating with beta-amyloid accumulation, a hallmark of the disease. Researchers analyzed brain tissue samples and cerebrospinal fluid, discovering higher active meprin-β levels in advanced stages of Alzheimer's. This study may aid in developing future treatments and understanding the biological complexities of Alzheimer's disease.